PDB33 - Delaying Second Line Diabetes Treatment Onset In Patients Uncontrolled With Metformin Xr In Saudi Arabia: Cost-Effectiveness Analysis

Journal article

Open access

Peer reviewed

H Al-Omar, M Alsultan, B Vandewalle, M Placido, M Afonso-Silva, M Mota, S Marques and J Félix

Value in health, Vol.20(9), pp.A480-A480

10/2017

Files and links (1)

url

https://doi.org/10.1016/j.jval.2017.08.460View

Published (Version of record) Open

1 Record Views

Title: PDB33 - Delaying Second Line Diabetes Treatment Onset In Patients Uncontrolled With Metformin Xr In Saudi Arabia: Cost-Effectiveness Analysis
Creators - without role: H Al-Omar - King Saud University
M Alsultan - King Saud University
B Vandewalle - Exigo Consultores, Lisbon, Portugal
M Placido - Exigo Consultores, Lisbon, Portugal
M Afonso-Silva - Exigo Consultores, Lisbon, Portugal
M Mota - Exigo Consultores, Lisbon, Portugal
S Marques - Exigo Consultores, Lisbon, Portugal
J Félix - Exigo Consultores, Lisboa, Portugal
Publication Details: Value in health, Vol.20(9), pp.A480-A480
Publisher: Elsevier Inc
Identifiers: 9952775508331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article